Predictive Value of Early MRI Measures for Long-Term Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis Receiving IFN β-1a SC tiw or IFN β-1a IM qw: Post Hoc Analyses of the EVIDENCE Study

被引：0
|
作者：
Coyle, Patricia [3 ]
Freedman, Mark [5 ,6 ]
Dangond, Fernando [1 ]
Fang, Juanzhi [2 ]
Reder, Anthony [4 ]
机构：
[1] EMD Serono Inc, Billerica, MA USA
[2] EMD Serono Inc, Rockland, MA USA
[3] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ Ottawa, Ottawa, ON, Canada
[6] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.189
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Long-term cost effectiveness of interferon-β-1a in the treatment of relapsing-remitting multiple sclerosis -: An econometric model
    Lepen, C
    Coyle, P
    Vollmer, T
    Blumhardt, L
    Lilliu, H
    Beresniak, A
    CLINICAL DRUG INVESTIGATION, 2003, 23 (09) : 571 - 581
  • [12] Long-term assessment of No Evidence of Disease Activity (NEDA) in patients with relapsing-remitting multiple sclerosis
    De Stefano, N.
    Stromillo, M. L.
    Giorgio, A.
    Bartolozzi, M. L.
    Battaglini, M.
    Baldini, M.
    Portaccio, E.
    Amato, M. P.
    Sormani, M. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 26 - 26
  • [13] No evident disease activity in relapsing MS patients treated with interferon β-1a SC vs. interferon β-1a IM: subgroup analyses of the EVIDENCE study
    Coyle, P. K.
    Fang, J.
    Hassan, A.
    Cha, C.
    Dangond, F.
    Reder, A. T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 114 - 114
  • [14] Safety of long-term monthly cycles of methylprednisolone in combination with interferon β-1a IM in treatment-naive early relapsing-remitting multiple sclerosis patients in the MECOMBIN trial
    Ravnborg, M.
    Sorensen, P. S.
    Andersson, M.
    Celius, E. Gulowsen
    Jongen, P.
    Batholome, E.
    Elovaara, I.
    Beer, K.
    Sperling, B.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S243 - S243
  • [15] Predictive value of EDSS worsening and relapse/active T2 lesions on outcomes among patients receiving IFN β-1a SC tiw for RRMS: post hoc analyses of PRISMS data over 4 years
    Cascione, M.
    Fang, J.
    Dangond, F.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 575 - 575
  • [16] Long term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis previously treated with interferon β-1a or disease modifying therapies: a post hoc analysis of the TRANSFORMS 4.5 year extension study
    Montalban, X.
    Barkhof, F.
    Comi, G.
    Hartung, H. -P.
    Kappos, L.
    Khatri, B.
    Pelletier, J.
    Kornyeyeva, E.
    Ritter, S.
    von Rosenstiel, P.
    Cohen, J.
    JOURNAL OF NEUROLOGY, 2013, 260 : S124 - S125
  • [17] Long-Term Adherence to IFN Beta-1α Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis
    Fernandez, O.
    Arroyo, R.
    Martinez-Yelamos, S.
    Marco, M.
    Garcia Merino, J. A.
    Munoz, D.
    Merino, E.
    Roque, A.
    PLOS ONE, 2016, 11 (08):
  • [18] Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study
    Lugaresi, Alessandra
    De Robertis, Francesca
    Clerico, Marinella
    Morra, Vincenzo Brescia
    Centonze, Diego
    Borghesan, Stefano
    Maniscalco, Giorgia Teresa
    EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (07) : 931 - 935
  • [19] Monthly cycles of methylprednisolone in combination with interferon β-1a IM are efficacious in the treatment of early relapsing-remitting multiple sclerosis. The MECOMBIN study
    Ravnborg, M.
    Sorensen, P. S.
    Andersson, M.
    Celius, E. Gulowsen
    Jongen, P.
    Bartholome, E.
    Elovaara, I.
    Beer, K.
    Constantinescu, C.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S14 - S14
  • [20] Relation of long-term exposure to subcutaneous interferon-β-1a with clinical outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS-15 study
    Kappos, L.
    Cornelisse, P.
    Lehr, L.
    Kuhle, J.
    Uitdehaag, B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 39 - 39
12345